A Novel NMDA Receptor Antagonist Protects against Cognitive Decline Presented by Senescent Mice

Alzheimer’s disease (AD) is the leading cause of dementia. Non-competitive N-Methyl-D-aspartate (NMDA) receptor antagonist memantine improved cognition and molecular alterations after preclinical treatment. Nevertheless, clinical results are discouraging. In vivo efficacy of the RL-208, a new NMDA r...

Descripción completa

Detalles Bibliográficos
Autores principales: Companys-Alemany, Júlia, Turcu, Andreea L., Bellver-Sanchis, Aina, Loza, Maria I, Brea, José M., Canudas, Anna M, Leiva, Rosana, Vázquez, Santiago, Pallàs, Mercè, Griñán-Ferré, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7151078/
https://www.ncbi.nlm.nih.gov/pubmed/32235699
http://dx.doi.org/10.3390/pharmaceutics12030284

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7151078/
https://www.ncbi.nlm.nih.gov/pubmed/32235699
http://dx.doi.org/10.3390/pharmaceutics12030284

Ejemplares similares